内皮素受体拮抗剂,endothelin receptor antagonist
1)endothelin receptor antagonist内皮素受体拮抗剂
1.Study on the quantitative structure-activity relationship of nonpeptideendothelin receptor antagonist: Bis-sulfonamides;二磺酰胺类内皮素受体拮抗剂的构效关系研究
2.Effects of ETP-508,a novelendothelin receptor antagonist,on the proliferation of pulmonary arterial smooth muscle cells of rat cultured in hypoxia environment;新型内皮素受体拮抗剂ETP-508对低氧培养大鼠肺动脉平滑肌细胞增殖的影响
3.Therapic effects of CPU0213,a novelendothelin receptor antagonist,on isopreterenol induced cardiomyopathy;内皮素受体拮抗剂CPU0213对异丙肾上腺素心肌病SERCA2a表达的改善作用
英文短句/例句
1.The Study of Cyclopeptide and Nonpeptide Endothelin Receptor Antagonists;环肽及非肽类内皮素受体拮抗剂的研究
2.Endothelin, Endothelin Receptor Antagonists and Diabetic Nephropathy Pathogenesis内皮素、内皮素受体拮抗剂与糖尿病肾病发病机制的研究进展
3.The Study on the Effect and Mechenisms of Endothelin Receptor Antagonist PD142893 Preconditioning on Allograft Ischemia/reperfusion Injury in Rat Lung Transplantation;内皮素受体拮抗剂PD142893对肺移植缺血再灌注损伤干预作用的研究
4.Study on the Quantitative Structure-activity & Pharmacokinetics Relationship and Molecule Design of Sulfonylamido Pyrimidines as Endothelin Receptor Antagonists;磺酰胺嘧啶类内皮素受体拮抗剂的构效/构动关系及分子设计
5.The Effect of the Non-Selective En-dothelin Receptor Antagonist TAK-044 on Cardiac Remodeling;内皮素受体拮抗剂TAK-044与高血压心脏重塑关系研究
6.The Effect of Endothelin Receptor Antagonist PD142893 on Renal Function Impairment of Rats with Obstructive Jaundice;内皮素受体拮抗剂PD142893对梗阻性黄疸大鼠并发肾功能损害的影响
7.Effects of the Novel Endothelin Receptor Antagonists on the Proliferation of Rat Pulmonary Arterial Smooth Muscle Cells;新型内皮素受体拮抗剂对大鼠肺动脉平滑肌细胞增殖的影响
8.Effects of ETP-508,a novel endothelin receptor antagonist,on bleomycin-induced pulmonary fibrosis in rats新型内皮素受体拮抗剂ETP-508对实验性大鼠肺纤维化的干预作用
9.The Effects of ET-RA on the P-selectin and E-selectin in Rats with Severe Acute Pancreatitis;重症急性胰腺炎动物模型中内皮素受体拮抗剂对P-选择素和E-选择素表达的影响
10.Experimental Study on the Effects of the Novel Endothelin Receptor Antagonist on Bleomycin-induced Pulmonary Fibrosis新型内皮素受体拮抗剂对博来霉素致肺纤维化干预作用的实验研究
11.The Pharmacodynamics Evaluation of Endothelin-receptor Antagonist in Pulmonary Hypertension and the Preliminary Research of Its Mechanism in Myocardial Hypertrophy内皮素受体拮抗剂的药效学评价及其在心肌肥厚中作用机制的初步研究
12.Effects of BQ-123 on Carcinoma Angiogenesis of Implanted Laryngeal Carcinoma内皮素A受体拮抗剂在人喉癌种植瘤的实验研究
13.Effects of Endothelin A Receptor Antagonist BQ123 on the Proliferation and Apoptosis of Prostate Cancer Cell Line PC-3M内皮素A受体拮抗剂BQ123对前列腺癌PC-3M细胞增殖与凋亡的影响
14.Pharmacophore modeling of dual angiotensin Ⅱ and endothelin A receptor antagonists血管紧张素受体和内皮素受体双重受体拮抗剂药效团模型的研究(英文)
15.The Effects of Endothelin-1 and ETAR,ETA Receptor Antagonist BQ123 on Pulmonary Hypertension Syndrome in Broiler;内皮素-1及其受体、受体拮抗剂在肺动脉高压综合征肉鸡中的作用研究
16.The relationship between interleukin-1,interleukin-1 receptor antagonist and restenosis after percutaneous transluminal angioplasty白细胞介素-1及白细胞介素-1受体拮抗剂与经皮腔内血管成形术后再狭窄的关系
17.Experimental Study of Protective Effects of Endothelin-1 Receptor Antagonist (BQ-123) in Rats Lung Ischemia-reperfusion Injury内皮素-1受体拮抗剂（BQ-123）对大鼠肺缺血—再灌注损伤保护作用的实验研究
18.Glucocorticiod and Glucocorticiod Cytosolic Receptors Antagonist Effect on the Trend of Apoptotic Eosinophils.;糖皮质激素与其胞浆受体拮抗剂对凋亡的嗜酸粒细胞转归的影响
相关短句/例句
endothelin receptor antagonists内皮素受体拮抗剂
1.Effects ofendothelin receptor antagonists on portal hypertension andET-1mRNA expression in cirrhotic portal hypertensive rat;内皮素受体拮抗剂对肝硬变门静脉高压症大鼠门静脉压及ET-1 mRNA表达的影响
3)endothelin A receptor antagonist内皮素A受体拮抗剂
4)Endothelin-1 receptor antagonist内皮素-1受体拮抗剂
5)melanocortin 4 receptor antagonists黑皮素4受体拮抗剂
6)glucocorticoid receptor antagonist糖皮质激素受体拮抗剂
1.Methods:The rats were randomly divided into 5 groups as follows:① rats with no medication receiving only normal saline (normal control,group A);②the rats were injected subcutaneously with dexamethasone (5 mg/kg,group B);③ rats were injected subcutaneously with dexamethasone (15 mg/kg,group C);④ rats were treated withglucocorticoid receptor antagonist RU38486 (10 mg/kg) by gavage (g.方法 :将大鼠随机分为5组 :1正常对照组 (A组 ) ;2皮下注射地塞米松 5 mg/kg组 (B组 ) ;3皮下注射地塞米松 15 mg/kg组(C组 ) ;4糖皮质激素受体拮抗剂 RU 384 86 (10 mg/kg)灌胃组 (D组 ) ;5皮下注射地塞米松 (15 mg/kg)前 2小时 RU 384 86 (10 mg/kg)灌胃组 (E组 )。
延伸阅读
内皮素受体内皮素受体目前对ETR的调节机制了解极少，可能雌激素促其形成，而孕激素有抑制作用。
